NEWS & EVENTS | OSLO UNIVERSITETSSYKEHUS - HOSPITAL PAGES IN NORWEGIAN

Publications

Dosimetry
  • Vestad TA, Malinen E, Olsen DR, Hole EO, Sagstuen E. Electron paramagnetic resonance (EPR) dosimetry using lithium formate in radiotherapy: comparison with thermoluminescence (TL) dosimetry using lithium fluoride rods. Phys Med Biol. 2004 Oct 21;49(20):4701-15. (View summary)

  • Olberg S, Skretting A, Bruland O, Olsen DR. Dose distribution measurements by MRI of a phantom containing lung tissue equivalent compartments made of ferrous sulphate gel. Phys Med Biol. 2000 Oct;45(10):2761-70. (View summary)

  • Furre T, Bergstrand ES, Pedersen E, Koritzinsky M, Olsen DR, Hole EO, Pettersen EO. Measurement of dose rate at the interface of cell culture medium and glass dishes by means of ESR dosimetry using thin films of alanine. Radiat Res. 1999 Jul;152(1):76-82. (View summary)

  • Knutsen BH, Skretting A, Hellebust TP, Olsen DR. Determination of 3D dose distribution from intracavitary brachytherapy of cervical cancer by MRI of irradiated ferrous sulphate gel. Radiother Oncol. 1997 May;43(2):219-27. (View summary)

  • Pedersen K, Andersen TD, Rodal J, Olsen DR. Sensitivity and stability of LiF thermoluminescence dosimeters. Med Dosim. 1995 Winter;20(4):263-7. (View summary)


Mathematical modelling
  • Johannessen HO, Dale E, Hellebust TP, Olsen DR, Nesland JM, Giercksky KE. Modeling volume effects of experimental brachytherapy in the rat rectum: uncovering the limitations of a radiobiologic concept. Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):1014-22. (View summary)

  • Olsen DR. Implications of radiation induced apoptosis on calculated radial cell inactivation for a linear 192Ir source. Acta Oncol. 1997;36(3):261-6. (View summary)

  • Olsen DR. Calculation of the biological effect of fractionated radiotherapy: the importance of radiation-induced apoptosis. Br J Radiol. 1995 Nov;68(815):1230-6. (View summary)

  • Olsen DR, Kambestad BK, Kristoffersen DT. Calculation of radiation induced complication probabilities for brain, liver and kidney, and the use of a reliability model to estimate critical volume fractions. Br J Radiol. 1994 Dec;67(804):1218-25. (View summary)

Normal tissue effects
  • Dale E, Olsen DR, Fossa SD. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):385-91. (View summary)

  • Lilleby W, Olsen DR, Fossa SD. Comparison of radiation side-effects in prostate cancer. Lancet. 1999 Apr 24;353(9162):1443. (View summary)

  • Lilleby W, Fossa SD, Waehre HR, Olsen DR. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):735-43. (View summary)

  • Evensen JF, Bjordal K, Knutsen BH, Olsen DR, Store G, Tausjo JE. Side effects and quality of life after inadvertent radiation overdosage in brachytherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):944-52. (View summary)

  • Fossa SD, Aass N, Winderen M, Bormer OP, Olsen DR. Long-term renal function after treatment for malignant germ-cell tumours. Ann Oncol. 2002 Feb;13(2):222-8. (View summary)

Experimental therapies
  • Wiig JN, Tveit KM, Poulsen JP, Olsen DR, Giercksky KE. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol. 2002 Feb;62(2):207-13. (View summary)

  • Furre T, Koritzinsky M, Olsen DR, Pettersen EO. Inverse dose-rate effect due to pre-mitotic accumulation during continuous low dose-rate irradiation of cervix carcinoma cells. Int J Radiat Biol. 1999 Jun;75(6):699-707. (View summary)

  • Aurlien E, Larsen RH, Akabani G, Olsen DR, Zalutsky MR, Bruland OS. Exposure of human osteosarcoma and bone marrow cells to tumour-targeted alpha-particles and gamma-irradiation: analysis of cell survival and microdosimetry. Int J Radiat Biol. 2000 Aug;76(8):1129-41. (View summary)

  • Olsen DR, Singstad TE, Rofstad EK. Effects of hyperthermia on bioenergetic status and phosphorus T1S in human melanoma xenografts monitored by 31P-MRS. Magn Reson Imaging. 1999 Sep;17(7):1049-56. (View summary)

MR and tumour physiology
  • Lyng H, Olsen DR, Petersen SB, Rofstad EK. 31P NMR spectroscopy studies of phospholipid metabolism in human melanoma xenograft lines differing in rate of tumour cell proliferation. NMR Biomed. 1995 Apr;8(2):65-71. (View summary)

  • Olsen DR, Lyng H, Petersen S, Rofstad EK. Spin-lattice relaxation time of inorganic phosphate in human tumor xenografts measured in vivo by 31P-magnetic resonance spectroscopy. Influence of oxygen tension. Acta Oncol. 1995;34(3):339-43. (View summary)

  • Olsen DR, Lyng H, Southon TE, Rofstad EK. 31P-nuclear magnetic resonance spectroscopy in vivo of four human melanoma xenograft lines: spin-lattice relaxation times. Radiother Oncol. 1994 Jul;32(1):54-62. (View summary)

  • Lyng H, Olsen DR, Southon TE, Rofstad EK. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply. Br J Cancer. 1993 Dec;68(6):1061-70. (View summary)

  • Olsen DR, Rofstad EK. Monitoring of tumor reoxygenation following irradiation by 31P magnetic resonance spectroscopy: an experimental study of human melanoma xenografts. Radiother Oncol. 1999 Sep;52(3):261-7. (View summary)


 
[2165 visits]
>> Go back   >> Print this page   >> E-mail this page